Genetics of skin tumor promotion

Progress in Experimental Tumor Research

Volumn 35, Issue , 1999, Pages 143-157

  Angel, Joe M ^a   Digiovanni, John ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HUMAN; MOUSE; MOUSE STRAIN; RAT; REVIEW; SKIN TUMOR;

ANIMALS; CARCINOGENS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, INBRED STRAINS; RATS; SKIN NEOPLASMS;

EID: 0032612197     PISSN: 00796263     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000062010     Document Type: Article

References (45)

1. Perera FP: Molecular epidemiology: Insights into cancer susceptibility, risk assessment and prevention. J Natl Cancer Inst 1996;88:496-509.
2. Ponder BAJ: Inherited predisposition to cancer. Trends Genet 1990;6:213-218.
3. DiGiovanni J: Genetic determinants of cancer susceptibility; in Bowden GT, Fischer SM (eds): Comprehensive Toxicology, Carcinogens and Anticarcinogens. New York, Pergamon Press, 1997, vol 10, pp 425-451.
4. Bennett LM, Winkler ML, Drinkwater NR: A gene that determines the high susceptibility of the C3H/HeJ strain of mouse to liver tumor induction is located on chromosome one. Proc Am Assoc Cancer Res 1993;34:144.
5. Gariboldi M, Manenti G, Canzian F, Falvella FS, Pierotti MA, Porta GD, Binelli G, Dragani TA: Chromsome mapping of murine susceptibility loci to liver carcinogenesis. Cancer Res 1993;53:209-211.
6. Lee G-H, Bennett LM, Carabeo RA, Drinkwater NR: Identification of hepatocarcinogen-resistance genes in DBA/2 mice. Genetics 1995;139:387-395.
7. Lee GH, Drinkwater NR: The Her (hepatocarcinogen resistance) loci of DBA/2J mice partially suppress phenotypic expression of the Hcs (hepatocarcinogen sensitivity) loci of C3H/HeJ. Carcinogenesis 1995;16:1993-1996.
8. Fijneman RJA, de Vries SS, Jansen RC, Demant P: Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 1996;14:465-467.
9. van Wezel T, Stassen APM, Moen CJA, Hart AAM, van der Valk MA, Demant P: Genetic interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet 1996;14:468-470.
10. Demant P: Genetic resolution of susceptibility to cancer-new perspectives. Cancer Biol 1992;3:159-166.
11. Muhlbock O, Dux A: Histocompatibility genes (the H-2 complex) and susceptibility to mammary tumor virus in mice. J Natl Cancer Inst 1974;53:993-996.
12. Zijlstra M, Melief CJM: Virology, genetics and immunology of murine lymphomagenesis. Biochim Biophys Acta 1986;865:197-231.
13. Oomen LCJM, van der Valk MA, Hart AAM, Demant P, Emmelot P: Influence of mouse major histocompatibility complex (H-2) on N-ethyl-N-nitrosourea-induced tumor formation in various organs. Cancer Res 1988;48:6634-6641.
14. Spitz MR, Bondy ML: Genetic susceptibility to cancer. Cancer 1993;72:991-995.
15. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 1994;266:1821-1828.
16. Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, Murai H, Nakatsuru Y, Ishikawa T, Hirota S, Kitamura Y, Kato Y, Tsunoda Y, Miyauchi H, Horio T, Tokunaga T, Matsunaga T, Nikaido O, Nishimune Y, Okada Y, Tanaka K: High incidence of ultraviolet-B or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 1995;377:165-168.
17. de Vries A, van Oostrom CT, Hofhuis FM, Dortant PM, Berg RJ, de Gruijl FR, Wester PW, van Kreijl CF, Capel PJ, van Steeg H, Verbeek JJ: Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 1995;377:169-173.
18. Sands AT, Sbuin A, Sanchez A, Conti CJ, Bradley A: High susceptibility to ultraviolet-induced carcinogenesis in mice lacking XPC. Nature 1995;377:162-165.
19. de Vries A, van Oostrom CT, Dortant PM, Beems RB, van Kreijl CF, Capel PJ, van Steeg H: Spontaneous liver tumors and benzo[a]pyrene-induced lymphomas in XPA-deficient mice. Mol Carcinog 1997;19:46-53.
20. Nebert DW: Role of genetics and drug metabolism in human cancer risk. Mutat Res 1991;247:267-281.
21. Boutwell RK: Some biological aspects of skin carcinogenesis. Prog Exp Tumor Res 1964;4:207-250.
22. Boutwell RK: The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 1974;2:419-443.
23. Terracini B, Shubik P, Della Porta G: A study of skin carcinogenesis in the mouse with single applications of 9,10-dimethyl-12-benzathracene at different dosages. Cancer Res 1960;20:1538-1542.
24. Turusov V, Day N, Andrianov L, Jain D: Influence of dose on skin tumor induced in mice by single application of 7,12-dimethylbenz(a)-anthracene. J Natl Cancer Inst 1971;47:105-111.
25. Slaga TJ: Cellular and molecular mechanisms involved in multistage skin carcinogenesis; in Conti CJ, Slaga TJ, Klein-Szanto AJP (eds): Skin Tumors: Experimental and Clinical Aspects. New York, Raven Press, 1989, pp 1-18.
26. DiGiovanni J: Multistage carcinogenesis in mouse skin. Pharmacol Ther 1992;54:63-128.
27. Yuspa SH: The pathogenesis of squamous cell cancer: Lessons learned from studies of skin carcinogenesis - Thirty-third G.H.A. Clowes Memorial Award Lecture. Cancer Res 1994;54:1178-1189.
28. Boutwell RK: The biochemistry of preneoplasia in mouse skin. Cancer Res 1976;36:2631-2635.
29. Slaga TJ: Mechanisms involved in two-stage carcinogenesis in mouse skin; in Slaga TJ (ed): Mechanisms of Tumor Promotion. Boca Raton, CRC Press, 1984, vol 2, pp 1-16.
30. DiGiovanni J: Genetics of susceptibility to mouse skin tumor promotion; in Sirica AE (ed): The Pathobiology of Neoplasia. New York, Plenum Press, 1989, pp 247-274.
31. Naito M, DiGiovanni J: Genetic background and development of skin tumors; in Conti CJ, Slaga TJ, Klein-Szanto AJP (eds): Skin Tumors: Experimental and Clinical Aspects. New York, Raven Press, 1989, pp 187-212.
32. Conti CJ: The mouse skin as a model for chemical carcinogenesis; in Sundberg JP (ed): Handbook of Mouse Mutations with Skin and Hair Abnormalities. Boca Raton, CRC Press, 1994, pp 39-55.
33. Yuspa SH, Poirer MC: Chemical carcinogenesis: From animal models to molecular models in one decade. Adv Cancer Res 1988;50:25-70.
34. Klein-Szanto AJP: Pathology of human and experimental skin tumors; in Conti CJ, Slaga TJ, Klein-Szanto AJP (eds): Skin Tumors: Experimental and Clinical Aspects. New York, Raven Press, 1989, pp 19-53.
35. Burns FJ, Albert RE, Altschuler B: Cancer progression in mouse skin; in Slaga TJ (ed): Mechanisms of Tumor Promotion: Tumor Promotion and Skin Carcinogenesis. Boca Raton, CRC Press, 1984, vol 2, pp 17-29.
36. Aldaz CM, Conti CJ: The premalignant nature of mouse skin papillomas: Histopathologic cytogenetic and biochemical evidence; in Conti CJ, Slaga TJ, Klein-Szanto AJP (eds): Skin Tumors: Experimental and Clinical Aspects. New York, Raven Press, 1989, pp 227-242.
37. Aldaz CM, Conti CJ, Klein-Szanto AJP, Slaga TJ: Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: Relevance to malignancy. Proc Natl Acad Sci USA 1987;84:2029-2032.
38. Aldaz CM, Trono D, Larcher F, Slaga TJ, Conti CJ: Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions. Mol Carcinog 1989;2:22-26.
39. Sundberg JP, Sund berg BA, Beamer WG: Comparison of chemical carcinogen skin tumor induction efficacy in inbred, mutant, and hybrid strains of mice: Morphologic variations of induced tumors and absence of a papillomavirus cocarcinogen. Mol Carcinog 1997;20:19-32.
40. DiGiovanni J: Genetic factors controlling responsiveness to skin tumor promotion in mice; in McClain RM, Slaga TJ, LeBoeuf R, Pilot H (eds): Growth Factors and Tumor Promotion: Implications for Risk Assessment. New York, Wiley-Liss, 1995, pp 195-212.
41. Naito M, Chenicek KJ, Naito Y, DiGiovanni J: Susceptibility to phorbol ester skin tumor promotion in C57BL/6 × DBA/2 F1 mice is inherited as an incomplete dominant trait: Evidence for multilocus involvement. Carcinogenesis 1988;4:639-645.
42. DiGiovanni J, Imamoto A, Naito M, Walker SE, Beltran LM, Chenicek KJ, Skow L: Further genetic analyses of tumor promotion susceptibility using inbred and recombinant inbred mice. Carcinogenesis 1992;13:525-531.
43. Angel JM, Beltran L, Minda K, Rupp T, DiGiovanni J: Association of a murine chromosome 9 locus (Psl1) with susceptibility to mouse skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Mol Carcinog 1997;20:162-167.
44. Nagase H, Bryson S, Cordell H, Kemp CJ, Fee F, Balmain A: Distinct genetic loci control development of benign and malignant skin tumours in mice. Nat Genet 1995;10:424-429.
45. Kruglyak L, Lander ES: A nonparametric approach for mapping quantitative trait loci. Genetics 1995;139:1421-1428.